Steven A. Pergam

8.0k total citations · 2 hit papers
153 papers, 5.0k citations indexed

About

Steven A. Pergam is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Steven A. Pergam has authored 153 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Epidemiology, 62 papers in Infectious Diseases and 55 papers in Oncology. Recurrent topics in Steven A. Pergam's work include Cytomegalovirus and herpesvirus research (27 papers), Hematopoietic Stem Cell Transplantation (25 papers) and Neutropenia and Cancer Infections (23 papers). Steven A. Pergam is often cited by papers focused on Cytomegalovirus and herpesvirus research (27 papers), Hematopoietic Stem Cell Transplantation (25 papers) and Neutropenia and Cancer Infections (23 papers). Steven A. Pergam collaborates with scholars based in United States, South Africa and Australia. Steven A. Pergam's co-authors include Michael Boeckh, Brenda M. Sandmaier, Ted Gooley, George B. McDonald, Paul J. Martin, Mohamed L. Sorror, Sangeeta Hingorani, Frederick R. Appelbaum, Rainer Storb and Ajit P. Limaye and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Steven A. Pergam

140 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

2010 1.0k citations Steven A. Pergam, Michael Boeckh et al. profile →
Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal

2020 367 citations Masumi Ueda, Steven A. Pergam et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven A. Pergam United States	33	1.8k	1.4k	1.4k	1.3k	858	153	5.0k
Rafael de la Cámara Spain	39	3.2k 1.8×	1.9k 1.4×	1.6k 1.2×	1.7k 1.3×	345 0.4×	154	5.7k
Dan Engelhard Israel	45	3.8k 2.1×	2.4k 1.7×	2.2k 1.6×	1.2k 0.9×	519 0.6×	167	7.3k
Simone Cesaro Italy	47	2.9k 1.5×	2.6k 1.9×	2.4k 1.8×	2.9k 2.2×	881 1.0×	289	8.3k
Thomas Lehrnbecher Germany	51	3.5k 1.9×	2.9k 2.1×	3.0k 2.2×	1.5k 1.2×	1.0k 1.2×	264	8.2k
Jo‐Anne H. Young United States	32	4.8k 2.6×	3.8k 2.8×	3.9k 2.8×	1.2k 0.9×	441 0.5×	96	9.0k
Alison G. Freifeld United States	37	3.7k 2.0×	3.7k 2.7×	2.8k 2.1×	377 0.3×	539 0.6×	97	7.4k
Albert Faye France	34	1.4k 0.7×	467 0.3×	2.2k 1.6×	251 0.2×	602 0.7×	210	4.7k
Danielle M. Zerr United States	40	3.2k 1.7×	1.3k 0.9×	1.7k 1.3×	251 0.2×	357 0.4×	165	5.1k
Llorenç Quintó Spain	42	2.4k 1.3×	611 0.4×	620 0.5×	275 0.2×	1.1k 1.3×	160	6.7k
Carlo Mengoli Italy	39	2.6k 1.4×	542 0.4×	2.4k 1.7×	522 0.4×	215 0.3×	134	4.6k

Countries citing papers authored by Steven A. Pergam

Since Specialization

Citations

This map shows the geographic impact of Steven A. Pergam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven A. Pergam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven A. Pergam more than expected).

Fields of papers citing papers by Steven A. Pergam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven A. Pergam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven A. Pergam. The network helps show where Steven A. Pergam may publish in the future.

Co-authorship network of co-authors of Steven A. Pergam

This figure shows the co-authorship network connecting the top 25 collaborators of Steven A. Pergam. A scholar is included among the top collaborators of Steven A. Pergam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven A. Pergam. Steven A. Pergam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lindsay, Julian, Elizabeth M. Krantz, Frank Tverdek, et al.. (2025). P-1750. Assessment of Antimicrobial Stewardship Guided CYP2C19 Pharmacogenomic Voriconazole Dosing: Practicalities and Impact on Clinical Management. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations

Harrington, Jennifer, et al.. (2025). Isolation precautions associated with COVID-19 infections among immunocompromised populations: A multicenter study of nine National Cancer Institute--designated Comprehensive Cancer Centers. American Journal of Infection Control. 53(5). 596–601.

Rosen, Emily A., Elizabeth M. Krantz, Denise J. McCulloch, et al.. (2024). COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 Therapeutics. Transplantation and Cellular Therapy. 30(11). 1108.e1–1108.e11. 2 indexed citations

Ueda, Masumi, et al.. (2023). Analysis of health care facility-onset Clostridioides difficile infection (CDI) in a hematopoietic cell transplant (HCT) unit: A call for diagnostic stewardship in a complex patient population. American Journal of Infection Control. 52(3). 374–376. 2 indexed citations

Lindsay, Julian, Carla S. Walti, Anna B. Halpern, et al.. (2023). Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms. Blood Advances. 7(13). 3140–3145. 3 indexed citations

Ford, Emily S., Genovefa A. Papanicolaou, Sanjeet Dadwal, Steven A. Pergam, & Amy Spallone. (2023). Frequently Asked Questions about Mpox (Formerly Monkeypox Disease) for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Recipients from the American Society for Transplantation and Cellular Therapy. Transplantation and Cellular Therapy. 29(5). 289–292. 2 indexed citations

Khawaja, Fareed, Genovefa A. Papanicolaou, Sanjeet Dadwal, et al.. (2022). Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology. Transplantation and Cellular Therapy. 29(1). 10–18. 10 indexed citations

Kim, Yae‐Jean, Alpana Waghmare, Hu Xie, et al.. (2022). Respiratory viruses in hematopoietic cell transplant candidates: impact of preexisting lower tract disease on outcomes. Blood Advances. 6(18). 5307–5316. 23 indexed citations

Krantz, Elizabeth M., et al.. (2022). Antibiotic prescribing knowledge: A brief survey of providers and staff at an ambulatory cancer center during Antibiotic Awareness Week 2019. SHILAP Revista de lepidopterología. 2(1). e18–e18. 1 indexed citations

10.

Walti, Carla S., Andrea N. Loes, Kiel Shuey, et al.. (2021). Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational study. Journal for ImmunoTherapy of Cancer. 9(10). e003428–e003428. 32 indexed citations

11.

Lindsay, Julian, Jad Othman, Sebastiaan J. van Hal, et al.. (2021). SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation. Open Forum Infectious Diseases. 8(11). ofab502–ofab502. 11 indexed citations

12.

Liu, Catherine, et al.. (2021). Advanced practice providers in the infectious disease workforce: A nationwide utilization survey. Journal of Interprofessional Education & Practice. 24. 100448–100448. 5 indexed citations

13.

Lindsay, Julian, Jad Othman, Michelle K. Yong, et al.. (2021). Dynamics of Epstein–Barr virus on post‐transplant lymphoproliferative disorders after antithymocyte globulin‐conditioned allogeneic hematopoietic cell transplant. Transplant Infectious Disease. 23(5). e13719–e13719. 7 indexed citations

14.

Lindsay, Julian, Jad Othman, Ian Kerridge, et al.. (2020). Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre‐transplant predictors of survival, reactivation, and spontaneous clearance. Transplant Infectious Disease. 23(3). e13548–e13548. 8 indexed citations

15.

Narita, Masahiro, et al.. (2020). A Targeted Screening Program for Latent Tuberculosis Infection Among Hematopoietic Cell Transplant Recipients. Open Forum Infectious Diseases. 7(7). ofaa224–ofaa224. 1 indexed citations

16.

Pergam, Steven A., Janet A. Englund, Mini Kamboj, et al.. (2019). Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation. 25(11). e321–e330. 19 indexed citations

17.

Pergam, Steven A., et al.. (2013). Multidrug-Resistant Bacteroides fragilis — Seattle, Washington, 2013. MMWR Morbidity and Mortality Weekly Report. 62(34). 694–696. 24 indexed citations

18.

Martin, Paul J., Terry Furlong, Scott D. Rowley, et al.. (2011). Evaluation of Oral Beclomethasone Dipropionate for Prevention of Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 18(6). 922–929. 16 indexed citations

19.

Pergam, Steven A.. (2007). Adverse Maternal and Neonatal Outcomes Associated with Maternal Hepatitis C Infection in Pregnancy. 1 indexed citations

20.

Haaland, Kathleen Y., Joseph Sadek, Steven A. Pergam, et al.. (2006). Mental Status after West Nile Virus Infection. Emerging infectious diseases. 12(8). 1260–1262. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact